Adenosine A2b Receptor antibody (C-Term)

Catalog No. ABIN929403

The Rabbit Polyclonal anti-Adenosine A2b Receptor antibody (ABIN929403) specifically detects Adenosine A2b Receptor in WB. The antibody is reactive with Human samples.

Quick Overview for Adenosine A2b Receptor antibody (C-Term) (ABIN929403)

Target: Adenosine A2b Receptor (ADORA2B)

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This Adenosine A2b Receptor antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-Adenosine A2b Receptor Antibody

Binding Specificity: C-Term

Purification: Purified

Immunogen: ADORA2 B antibody was raised in rabbit using the C terminal of ADORA2 as the immunogen

Application Details

Application Notes: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

ADORA2B Blocking Peptide, (ABIN5611959), is also available for use as a blocking control in assays to test for specificity of this ADORA2B antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Target Details for Adenosine A2b Receptor

Target: Adenosine A2b Receptor (ADORA2B)

Alternative Name: ADORA2B

Background: This gene encodes an adenosine receptor that is a member of the G protein-coupled receptor superfamily. This integral membrane protein stimulates adenylate cyclase activity in the presence of adenosine. This protein also interacts with netrin-1, which is involved in axon elongation. The gene is located near the Smith-Magenis syndrome region on chromosome 17. Synonyms: Polyclonal ADORA2B antibody, Anti-ADORA2B antibody, adenosine A2b receptor antibody, ADORA2 antibody.

Pathways: cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process